Disease Burden
2017 | 2019-20206 | 2021-20226 | |||
Prevalence among adults aged 18 to 69 years 1,2(%) | |||||
► Hyperlipidaemia | 35.5 | 39.1 | 39.1 | ||
► Hypertension | 24.2 | 35.5 | 37.0 | ||
► Diabetes | 8.8 | 9.5 | 8.5 | ||
► Obesity | 8.6 | 10.5 | 11.6 | ||
2020 | 2021 | 2022 | |||
► Daily Smoking | 10.1 | 10.4 | 9.2 | ||
Definitions:
Hyperlipidaemia: LDL-Cholesterol ≥ 4.1mmol/l
Hypertension: Blood pressure ≥ 140/90mmHg
Diabetes: Fasting plasma glucose ≥ 6.9 mmol/l
Obesity: BMI ≥ 30kg/m 2
Daily Smoking: Smokes cigarettes at least once a day
na - not available
Top 5 Leading Cancers 2,3 (Incidence, 2017 - 2021)
Male | Number | ASIR 4 | Female | Number | ASIR 4 |
1) Prostate | 6,912 | 36.5 | 1) Breast | 12,735 | 74.6 |
2) Colon & rectum | 6,697 | 37.5 | 2) Colon-rectum | 5,542 | 26.9 |
3) Lung | 5,567 | 30.0 | 3) Lung | 3,388 | 16.2 |
4) Lymphoid neoplasms | 2,986 | 20.0 | 4) Uterus | 3,133 | 18.8 |
5) Liver | 2,984 | 16.4 | 5) Lymphoid neoplasms | 2,221 | 13.6 |
Distribution of Disability-Adjusted Life Years (DALYs) (%) in Singapore by Broad-Cause Disease Group, 20215
.png)
 Filter.png)
A total of 1,093,274 life-years were lost due to mortality and poor health in Singapore in 2021.
Notes:
1 - Data for years 1992, 1998, 2004 and 2010 is from the National Health Survey (NHS) series, while data for years 2013 and 2017 is from the National Health Surveillance Survey (NHSS) 2013 and National Population Health Surveys (NPHS)2017 respectively.
2 - Singapore Residents.
3 - Source: Singapore Cancer Registry (SCR) Anniversary Monograph (1968-2017).
4 - ASIR: Age-Standardised Incidence Rate per 100,000 population (per year). The direct method based on the Segi-Doll World Standards was used to calculate the ASIRs.
5 - Source: Global Burden of Disease (GBD) 2021 study.
6 - Obesity and DHL prevalence are based on the Health Examination (HE) which is only reported every 2 years under NPHS.